FirstString Research, Inc.   Report issue

For profit Phase 1 Phase 3
Founded: Mount Pleasant SC United States (2005)

Organization Overview

First Clinical Trial
2008
NCT04473859
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

CEO | FirstString Research, Inc.

Active Ingredients

Drugs in Phase 3 Trials (1)

aCT1 (7 trials)

Drugs in Phase 1 Trials (2)

fsr peptide (1 trial)

spr-3d (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Foot (Phase 3)

Foot Ulcer (Phase 3)

Leg Ulcer (Phase 1)

Surgical Wound (Phase 3)

Ulcer (Phase 3)

Varicose Ulcer (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 9
  • # of Trial APIs: 3